Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

Hence, we propose DLS as a surrogate or substitute for IHC-determined PD-L1 measurement to guide individual pretherapy decisions pending in larger prospective trials.